Genmab, argenx Partner on Antibody Therapies in Immunology and Oncology

 

• Genmab and argenx have entereda multiyear collaborationbringing together capabilities to jointly discover, develop and commercialize antibody therapies
• Discovery programs against two differentiated targets are underway

https://www.biospace.com/article/releases/genmab-and-argenx-enter-partnership-to-advance-antibody-therapies-in-immunology-and-oncology/